Implants allow blind to 'see'
Researchers are working on new prosthetics that restore sight by delivering visual information directly to the brain.
For most adults who lose their vision, blindness results from damage to the eyes or optic nerve while the brain remains intact.
One way to prevent this would be through a device that could restore sight by bypassing damaged eyes and delivering visual information from a camera directly to the brain.
Researchers say they are now one step closer to this goal.
A team in the US has described an approach in which implanted electrodes are stimulated in a dynamic sequence, essentially ‘tracing’ shapes on the surface of the visual cortex that participants were able to ‘see’.
“When we used electrical stimulation to dynamically trace letters directly on patients' brains, they were able to 'see' the intended letter shapes and could correctly identify different letters,” senior author Daniel Yoshor says.
“They described seeing glowing spots or lines forming the letters, like skywriting.”
Previous attempts to stimulate the visual cortex have been less successful. Earlier methods treated each electrode like a pixel in a visual display, stimulating many of them at the same time. Participants could detect spots of light but found it hard to discern visual objects or forms.
“Rather than trying to build shapes from multiple spots of light, we traced outlines,” says first author Michael Beauchamp.
“Our inspiration for this was the idea of tracing a letter in the palm of someone's hand.”
The investigators tested the approach in sighted people who had electrodes implanted in their brains to monitor epilepsy and two blind people who had electrodes implanted over their visual cortex as part of a study of a visual cortical prosthetic device.
Stimulation of multiple electrodes in sequences produced perceptions of shapes that subjects were able to correctly identify as specific letters.
The approach, the researchers say, demonstrates that it could be possible for blind people to regain the ability to detect and recognise visual forms by using technology that inputs visual information directly into the brain, should they wish to.
The researchers note, however, that several obstacles must be overcome before this technology could be implemented in clinical practice.
“The primary visual cortex, where the electrodes were implanted, contains half a billion neurons. In this study we stimulated only a small fraction of these neurons with a handful of electrodes,” Dr Beauchamp says.
“An important next step will be to work with neuroengineers to develop electrode arrays with thousands of electrodes, allowing us to stimulate more precisely. Together with new hardware, improved stimulation algorithms will help realize the dream of delivering useful visual information to blind people.”